Characterization of T-Cell Receptor Repertoire in Patients with Rheumatoid Arthritis Receiving Biologic Therapies

Table 1

Clinical characteristics of rheumatoid arthritis patients.

ID	Gender	Age	Treatment	DAS^1	ESR^2	CRP^3	CDAI^4	SDAI^5
A1	Female	64	Adalimumab	2.27	5	0.1	6.5	6.6
A2	Female	60	Adalimumab	1.46	6	0.1	3	3.1
R1	Female	42	Rituximab	1.8	11	0.5	2	2.5
R2	Female	72	Rituximab	2.13	14	0.1	3	3.1
R3	Female	65	Rituximab	2.02	6	0.2	4.5	4.7
T1	Female	61	Tocilizumab	1.96	2	0.1	8.5	8.6
T2	Female	48	Tocilizumab	1.19	2	0.2	3	3.2
T3	Female	47	Tocilizumab	2.2	5	0.1	6	6.2

¹DAS: disease activity score; ²ESR: erythrocyte sedimentation rate; ³CRP: C-reactive protein; ⁴CDAI: clinical disease activity index; ⁵SDAI: simple disease activity index.